What is the difference between MGF and Mod-GRF(1-29)?

MGF: MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical loading (exercise, especially eccentric loading). Unlike circulating IGF-1 which is produced primarily by the liver, MGF is generated within the muscle itself and acts locally to activate satellite cells (muscle stem cells) — the cells responsible for muscle repair, growth, and adaptation. It is considered the primary local anabolic signal generated by resistance training. Mod-GRF(1-29): Mod-GRF(1-29) is a stabilized analog of growth hormone-releasing hormone (GHRH) that spans residues 1–29 of the native peptide. Unlike CJC-1295 (which includes a Drug Affinity Complex for multi-day half-life), Mod-GRF(1-29) has a short ~30-minute active window — mimicking the natural GHRH pulse pattern. It is the preferred GHRH component for precise, pulsatile GH protocols when combined with a GHRP. Both are in the Performance & Growth Hormone category but differ in mechanism, dosing, and research evidence — see the full comparison.

Can you take MGF and Mod-GRF(1-29) together?

There is no specific, well-documented interaction rule for combining MGF and Mod-GRF(1-29) in the aggregated research reviewed. Combining peptides should only be considered under professional supervision. This is not medical advice.

Which is better researched, MGF or Mod-GRF(1-29)?

MGF is currently preclinical only and Mod-GRF(1-29) is research-stage. "Better researched" depends on your research goal — review each profile's cited sources.

Performance & Growth Hormone · Comparison

MGF vs Mod-GRF(1-29)

A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.

MGF

Preclinical only

MGF (Mechano Growth Factor) is a splice variant of IGF-1 produced locally in muscle tissue in response to mechanical loading (exercise, especially eccentric loading). Unlike circulating IGF-1 which is produced primarily by the liver, MGF is generated within the muscle itself and acts locally to activate satellite cells (muscle stem cells) — the cells responsible for muscle repair, growth, and adaptation. It is considered the primary local anabolic signal generated by resistance training.

Full profile

Mod-GRF(1-29)

Research-stage

Mod-GRF(1-29) is a stabilized analog of growth hormone-releasing hormone (GHRH) that spans residues 1–29 of the native peptide. Unlike CJC-1295 (which includes a Drug Affinity Complex for multi-day half-life), Mod-GRF(1-29) has a short ~30-minute active window — mimicking the natural GHRH pulse pattern. It is the preferred GHRH component for precise, pulsatile GH protocols when combined with a GHRP.

Full profile

	MGF	Mod-GRF(1-29)
Category	Performance & Growth Hormone	Performance & Growth Hormone
Also known as	Mechano Growth Factor, IGF-1Ec, Insulin-like Growth Factor splice variant	Modified GRF(1-29), CJC-1295 without DAC, Tetrasubstituted GRF, Sermorelin analog
Evidence	Preclinical only	Research-stage
Dosing range	100mcg–300mcg mcg, Post-workout (within 30–60 minutes of training), 3–4x weekly	100mcg–200mcg mcg, 2–3x daily, co-administered with a GHRP (pre-sleep, pre-workout, and/or upon waking)
Administration	Intramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution)	Subcutaneous injection, Intramuscular injection
Key side effects	Localized muscle swelling at injection site (normal response), Hypoglycemia (less pronounced than IGF-1 DES but present), Very short half-life means side effects are brief, Potential overuse injury if post-workout injection is used consistently without adequate recovery	Water retention (mild, dose-dependent), Tingling / numbness in extremities (carpal tunnel-like at high doses), Increased appetite (via GHRP component — less with Mod-GRF alone), Flushing or warmth at injection site
Cited sources	3 references	2 references

Key differences

Evidence level differs: MGF is preclinical only, while Mod-GRF(1-29) is research-stage.
Administration: MGF — Intramuscular injection (into worked muscle — critical for local effect), Subcutaneous injection (produces more systemic distribution); Mod-GRF(1-29) — Subcutaneous injection, Intramuscular injection.
Frequency: MGF is typically Post-workout (within 30–60 minutes of training), 3–4x weekly; Mod-GRF(1-29) is 2–3x daily, co-administered with a GHRP (pre-sleep, pre-workout, and/or upon waking).
Research depth: this profile cites 3 sources for MGF vs 2 for Mod-GRF(1-29).

How each works

MGF

MGF is encoded by the IGF-1 gene but produced via alternative splicing that generates a unique 49-amino acid C-terminal E-peptide (Ec peptide). The Ec peptide has distinct biological activity from the IGF-1 domain — it directly activates satellite cell proliferation through a receptor pathway separate from the standard IGF-1R. Studies in rodents show that local MGF injection produces significant muscle hypertrophy in the injected limb without systemic IGF-1 elevation. MGF expression spikes within 30 minutes of resistance exercise and declines over 24–48 hours — aligning precisely with the post-exercise anabolic window.

Mod-GRF(1-29)

Native GHRH(1-29) is rapidly cleaved by plasma dipeptidyl peptidase IV (DPP-IV) within 2–3 minutes. Mod-GRF(1-29) incorporates four amino acid substitutions (positions 2, 8, 15, 27) that resist DPP-IV degradation, extending the half-life to approximately 30 minutes while preserving GHRH receptor binding affinity. This creates a half-life window aligned with physiological GH pulsatility, making it suitable for 2–3x daily injections that mimic natural GH release patterns.

Read the full MGF profile Read the full Mod-GRF(1-29) profile

This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.